Gliclazide Sandoz 30 mg tabl. modif.-rel.

Valsts: Beļģija

Valoda: angļu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktīvā sastāvdaļa:

Gliclazide 30 mg

Pieejams no:

Sandoz SA-NV

ATĶ kods:

A10BB09

SNN (starptautisko nepatentēto nosaukumu):

Gliclazide

Deva:

30 mg

Zāļu forma:

Modified-release tablet

Kompozīcija:

Gliclazide 30 mg

Ievadīšanas:

Oral use

Ārstniecības joma:

Gliclazide

Produktu pārskats:

CTI code: 474177-02 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474177-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474177-04 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474177-03 - Pack size: 60 - Commercialisation status: YES - FMD code: 07613421001988 - CNK code: 2775195 - Delivery mode: Medical prescription; CTI code: 474177-06 - Pack size: 180 - Commercialisation status: YES - FMD code: 07613421001971 - CNK code: 2775187 - Delivery mode: Medical prescription; CTI code: 474177-05 - Pack size: 120 - Commercialisation status: NO - Delivery mode: Medical prescription

Autorizācija statuss:

Commercialised: Yes

Autorizācija datums:

2015-05-28